UBS AG - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALTU and the CUSIP is 363225301. A total of 2 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$3,000
-72.7%
254
-16.4%
0.00%
Q2 2014$11,000
-8.3%
304
+7.0%
0.00%
Q1 2014$12,000
+200.0%
284
-19.3%
0.00%
Q4 2013$4,000
-66.7%
352
-31.5%
0.00%
Q3 2013$12,000
+71.4%
514
-28.8%
0.00%
Q2 2013$7,0007220.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
UBS AG 352$4,0000.00%
Tower Research Capital LLC (TRC) 240$2,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders